A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) Meeting Abstract


Authors: Kelly, W.; O'connor, O.; Richon, V. M.; Tong, W.; Rao, T. D.; Chiao, J.; O'Brien, J. P.; Rifkind, R. A.; Marks, P. A.; Scher, H. I.
Abstract Title: A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)
Meeting Title: 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title: European Journal of Cancer
Volume: 38
Issue: Suppl. 7
Meeting Dates: 2002 Nov 19-22
Meeting Location: Frankfurt, Germany
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2002-11-01
Start Page: S88
Language: English
ACCESSION: WOS:000179895700288
PROVIDER: wos
DOI: 10.1016/S0959-8049(02)80937-6
PUBMED: 12526123
Notes: Meeting Abstract: 286 -- 14th EORTC/NCI/AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 19-22, 2002 -- FRANKFURT, GERMANY -- Source: Wos
Altmetric Score
MSK Authors
  1. William Ping-Yiu Tong
    133 Tong
  2. William K Kelly
    112 Kelly
  3. Dharmarao Thapi
    33 Thapi
  4. Howard Scher
    847 Scher
  5. Paul Marks
    143 Marks
  6. Richard Rifkind
    75 Rifkind